Docefrez
Docefrez (docetaxel) is an antineoplastic agent (chemotherapy drug) belonging to the taxane class of medications. It works by disrupting the microtubular network in cells, which is essential for mitotic and interphase cellular functions, thereby inhibiting cancer cell division and inducing cell death.
Dosage by Body Weight
Administered strictly as an intravenous infusion by a healthcare professional in a specialized clinical setting. The dose is highly individualized and typically calculated based on the patient's Body Surface Area (BSA in m²), liver function, and specific cancer type. Premedication with oral corticosteroids (such as dexamethasone) is usually required starting the day before infusion to reduce fluid retention and severity of hypersensitivity reactions.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of docetaxel in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of docetaxel in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of docetaxel in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of docetaxel in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of docetaxel in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness of docetaxel in pediatric patients have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness of docetaxel in pediatric patients have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness of docetaxel in pediatric patients have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness of docetaxel in pediatric patients have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness of docetaxel in pediatric patients have not been established. |
Formulation
Purpose
Used for the treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer, and metastatic prostate cancer.
Generic Name
DocetaxelScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.